MedPath

ALTERED FRACTIONATED RADIOTHERAPY SCHEDULES IN ORAL CAVITY CANCERS

Phase 2
Registration Number
CTRI/2013/05/003650
Lead Sponsor
REGIONAL CANCER CENTRE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1.Histologically proven squamous cell carcinoma of oral cavity

2.T1 to T4a(skin) N0 N1 disease intended to be treated with radical radiotherapy

3.ECOG Performance Status 0,1

4.Patients willing to participate in the study.

Exclusion Criteria

1.Age <18 or >70 yrs.

2.Non squamous cell carcinoma of head and neck region

3.N2 & above

4.Field size > 81 sq cm

5.Prior chemotherapy & radiotherapy

6.Metastatic disease

7.Pregnant women

8.Mentally unfit to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Response Rate <br/ ><br>2.Toxicity <br/ ><br>3.QOLTimepoint: 5 TO 6 MONTHS AFTER COMPLETION OF TREATMENT
Secondary Outcome Measures
NameTimeMethod
1.Disease free survival <br/ ><br>2.Overall survival <br/ ><br>Timepoint: 5 TO 6 MONTHS AFTER COMPLETION OF TREATMENT
© Copyright 2025. All Rights Reserved by MedPath